SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending with significant bullish momentum following news of efforts to reduce mortgage rates, sparking widespread community discussion about a potential short squeeze. The market believes this development could greatly benefit the platform by increasing housing market activity and transaction volumes. While many anticipate a strong upward move, some community members remain cautious about sector-wide hype.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is actively trending amid intense political discourse following a controversial incident involving federal agents, with the community sharply divided over the justification and legality of the use of force. This event is prompting broader conversations around law enforcement authority and civil liberties, while simultaneously drawing attention to recent policy proposals from the former president regarding housing affordability and mortgage bonds, and reigniting discussions about the Epstein files.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is a prominent trending stock, driven by widespread community discussion around its potential prime contractor role in a significant drone-based border security project for Israel, which is being viewed as a major validation of its autonomous defense systems. This news, though unconfirmed by the company, has ignited strong bullish sentiment and speculation about a substantial growth "super cycle" within the broader drone and defense technology sector.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Crypto is actively trending as its 'Wolfpack' community celebrates the successful launch of WolfSWAP, a cross-chain aggregator offering unique fee-sharing capabilities for other projects. This dedicated focus on building innovative utility beyond traditional memecoins, with further flagship products anticipated, is generating strong bullish sentiment and a vision for decentralizing the sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving pivotal FDA feedback, which clarified a de-risked path for its lead therapy, sonelokimab, towards regulatory submission without requiring additional clinical trials. This significant regulatory clarity has ignited widespread community discussion about potential buyouts, particularly by Merck, and the stock's substantial undervaluation. Investors are actively anticipating a major re-rating and a potential short squeeze, with upcoming investor events adding to the positive sentiment.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

MELANIA CRYPTO is actively trending, stirring heated debate as a political meme coin associated with Melania Trump. While some community members speculate on potential future catalysts, such as an upcoming movie or new deals, to drive a significant price increase, a strong undercurrent of discussion labels it a "scam" or "rug pull," citing substantial reported investor losses and concerns over continuous token dilution. This divergence underscores the highly speculative nature and perceived risks of assets tied to prominent political personalities.

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Inmode Ltd

InMode is a hot topic following a mixed earnings report, where better-than-expected Q3 results and an FDA clearance for Morpheus8 are overshadowed by lowered full-year guidance. Investors are deeply split: many see a heavily undervalued company with a strong balance sheet poised for a rebound, while others point to management's perceived missteps and a challenging aesthetic market as reasons for continued skepticism.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to significant U.S. and U.K. defense contracts, solidifying its position as an end-to-end national security space partner. The community is buzzing with anticipation for the Neutron rocket's debut and strong institutional interest, while some investors debate the current valuation and recent insider share transactions.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies (RKT) is trending on widespread excitement over proposed actions by President Trump to boost housing affordability, including a $200 billion mortgage bond purchase to lower rates and potential restrictions on institutional home buying. The community is highly bullish, anticipating a significant "refinance boom" and a "short squeeze" that could propel the stock to new highs. Investors see RKT as uniquely positioned to capitalize on these macro tailwinds due to its integrated platform and strategic acquisitions within the housing market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know

Pacific Biosciences of California (PACB) concluded the recent trading session at $2.13, signifying a +2.4% move from its prior day's close.

Here's Why You Should Add PacBio Stock to Your Portfolio

PACB is gaining from product development and strong Q3 results, with Revio and Vega driving growth, though longer purchasing cycles remain a risk.

Three Genomics Stocks Worth Tracking This Year 

Genomics advances are reshaping drug discovery, with Pacific Biosciences of California emerging as a key player in next-gen sequencing.

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up - Time to Buy?

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up - What's Next...

Pacific Biosciences of California (NASDAQ:PACB) Shares Up 7.1% - Should You Buy?

Pacific Biosciences of California (NASDAQ:PACB) Trading 7.1% Higher - Here's What Happened...

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 5.1% - What's Next?

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.1% - Here's Why...

Pacific Biosciences of California Target of Unusually Large Options Trading (NASDAQ:PACB)

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) was the target of unusually large options trading on Monday. Traders bought 8,267 call options on the company. This represents...

Amiral Gestion Invests $3.21 Million in Pacific Biosciences of California, Inc. $PACB

Amiral Gestion purchased a new position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) during the second quarter, according to the company in its most recent Form...

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3% - Here's Why

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 5.3% - Should You Sell...

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 5.3% - Here's What Happened

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 5.3% - Should You Sell...

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Pacific Biosciences of California Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$2.04
Prev Close	$2.13
Open	$2.13
Dividend Yield	0.00%
50-Day Moving Average	$2.02
Beta	2.12
Avg. Volume	6.39M
PE Ratio	-0.94

52-Week High	$2.73
52-Week Low	$0.8511
Market Capitalization	$643.06M
EPS (Annual)	-$1.59
Price to Book	17.06
Revenue Per Employee	$267,850.43
Enterprise Value/EBITDA	N/A

PACB
Pacific Biosciences of California Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PACB News

PACBPacific Biosciences of California Inc